Efficacy and Safety of Treatment Venetoclax Monotherapy or Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in the Real-World Setting in Spain: An Update of the Venares Study

Autor:	Ferra, Christelle ^, Terol, María José ^, Marquet Palomanes, Juan ^, Ramírez Payer, Angel ^, Moreno, Carol ^, Osorio, Santiago ^, De la Cruz, Fátima ^, Garcia-Marco, Jose A., Ortiz, Macarena ^, Rios Herranz, Eduardo ^, Magnano, Laura ^, Iraheta, Sandra ^, Puerta, Jose Manuel ^, de la Serna, Javier ^, Smucler, Alicia ^, Arguiñano, Jose Maria ^, Loscertales, Javier ^, Muiña, Begoña ^, Fernández, Rubén ^, García, Tomas ^, Márquez, José A. ^, Muntañola Prat, Ana ^, Perez Persona, Ernesto ^, Yáñez, Lucrecia ^, Pérez-Encinas, Manuel ^, González Díaz, Marcos ^, Caballero, Gonzalo ^, Andreu, María Angeles ^, Andreu, Rafael ^, Ruiz-Zorrilla, Ana ^, Moreno, Diana ^, Baltasar, Patricia ^*
Zdroj:	In Blood 15 November 2022 140 Supplement 1:9908-9910
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu